Literature DB >> 30553904

Heart Failure and Liver Disease: Cardiohepatic Interactions.

Andrew Xanthopoulos1, Randall C Starling1, Takeshi Kitai2, Filippos Triposkiadis3.   

Abstract

Heart failure (HF) and liver disease often co-exist. This is because systemic disorders and diseases affect both organs (alcohol abuse, drugs, inflammation, autoimmunity, infections) and because of complex cardiohepatic interactions. The latter, which are the focus of this review, include the development of acute cardiogenic liver injury and congestive hepatopathy in HF as well as cardiac dysfunction and failure in the setting of liver cirrhosis, nonalcoholic fatty liver disease, and sequelae following liver transplantation. The emerging role of altered liver X receptor signaling in the pathogenesis of HF comorbidities as well as of the intestinal microbiome and its metabolites in HF and liver disease are fruitful areas for future research.
Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  gut microbiota; heart failure; interactions; liver; liver X receptor

Mesh:

Year:  2018        PMID: 30553904     DOI: 10.1016/j.jchf.2018.10.007

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN: 2213-1779            Impact factor:   12.035


  34 in total

1.  Micro-scale assessment of bone quality changes in adult cadaveric men with congestive hepatopathy.

Authors:  Jelena Jadzic; Nada Tomanovic; Danica Djukic; Vladimir Zivkovic; Slobodan Nikolic; Marija Djuric; Petar Milovanovic; Danijela Djonic
Journal:  Histochem Cell Biol       Date:  2022-07-18       Impact factor: 2.531

2.  Predictive value of the Fibrosis-4 index in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.

Authors:  Vedat Tiyerili; Baravan Al-Kassou; Mitsumasa Sudo; Jasmin Shamekhi; Alexander Sedaghat; Adem Aksoy; Andreas Zietzer; Tetsu Tanaka; Nihal Wilde; Marcel Weber; Jan-Malte Sinning; Eberhard Grube; Verena Veulemans; Matti Adam; Malte Kelm; Stephan Baldus; Georg Nickenig; Sebastian Zimmer
Journal:  Clin Res Cardiol       Date:  2022-07-19       Impact factor: 6.138

3.  Molecular imaging of fibroblast activity in pressure overload heart failure using [68 Ga]Ga-FAPI-04 PET/CT.

Authors:  Guokun Wang; Qinqin Yang; Chao Cheng; Suxuan Liu; Shengyong Wu; Xudong Xu; Xiao Li; Siyu Liang; Guixia Pan; Changjing Zuo; Xianxian Zhao
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-09-29       Impact factor: 10.057

4.  Increases in Hepatokine Selenoprotein P Levels Are Associated With Hepatic Hypoperfusion and Predict Adverse Prognosis in Patients With Heart Failure.

Authors:  Ryohei Takeishi; Tomofumi Misaka; Yasuhiro Ichijo; Shinji Ishibashi; Mitsuko Matsuda; Yukio Yamadera; Himika Ohara; Yukiko Sugawara; Yu Hotsuki; Koichiro Watanabe; Fumiya Anzai; Yu Sato; Takamasa Sato; Masayoshi Oikawa; Atsushi Kobayashi; Takayoshi Yamaki; Kazuhiko Nakazato; Akiomi Yoshihisa; Yasuchika Takeishi
Journal:  J Am Heart Assoc       Date:  2022-05-27       Impact factor: 6.106

5.  Prognostic Value of Modified Model for End-Stage Liver Disease Score in Patients Undergoing Isolated Tricuspid Valve Replacement.

Authors:  Hongjie Xu; He Wang; Shisong Chen; Qian Chen; Tianyu Xu; Zhiyun Xu; Yangyong Sun
Journal:  Front Cardiovasc Med       Date:  2022-07-01

Review 6.  A right ventricular state of mind in the progression of heart failure with reduced ejection fraction: implications for left ventricular assist device therapy.

Authors:  Ersilia M DeFilippis; Marco Guazzi; Paolo C Colombo; Melana Yuzefpolskaya
Journal:  Heart Fail Rev       Date:  2021-11       Impact factor: 4.214

Review 7.  Risk-Based Approach for the Prediction and Prevention of Heart Failure.

Authors:  Arjun Sinha; Deepak K Gupta; Clyde W Yancy; Sanjiv J Shah; Laura J Rasmussen-Torvik; Elizabeth M McNally; Philip Greenland; Donald M Lloyd-Jones; Sadiya S Khan
Journal:  Circ Heart Fail       Date:  2021-02-04       Impact factor: 8.790

8.  Prognostic Role of Hepatorenal Function Indexes in Patients With Ebstein Anomaly.

Authors:  Alexander C Egbe; William R Miranda; Joseph Dearani; Patrick S Kamath; Heidi M Connolly
Journal:  J Am Coll Cardiol       Date:  2020-12-22       Impact factor: 24.094

9.  Pathogenic characteristics of pulmonary infection in hospitalized patients with chronic heart failure and diagnostic value of sTREM-1, sCD163, and sTWEAK.

Authors:  Fang Zheng
Journal:  Pak J Med Sci       Date:  2022 Mar-Apr       Impact factor: 1.088

10.  Patient Characteristics and Outcomes of Type 2 Myocardial Infarction During Heart Failure Hospitalizations in the United States.

Authors:  Salik Nazir; Abdul Mannan Khan Minhas; Ishan S Kamat; Robert W Ariss; George V Moukarbel; Juan Carlos Plana Gomez; Savitri Fedson; Ajith Nair; Biykem Bozkurt; Hani Jneid
Journal:  Am J Med       Date:  2021-06-30       Impact factor: 5.928

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.